

Dec 11 (Reuters) - Boston Scientific Corp 
* Says US FDA advisory committee votes 13-1 that benefits of
Watchman anti-stroke device outweigh risks 

FILED UNDER:   
http://feeds.reuters.com/~r/reuters/companyNews/~3/oPdA18xiL_4/story01.htm